FundedIQ

Recently Funded Biotechnology Startups in South San Francisco

Updated Sep 2026

There are 60 funded Biotechnology startups in South San Francisco in the FundedIQ database, each with its funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Biotechnology startup funding landscape in South San Francisco, along with the 60 most recently funded Biotechnology startups in South San Francisco.

Biotechnology startups in South San Francisco closed 38 funding rounds over the last 24 months, 21 of them in the last 12 months, and raised $5.2B in disclosed capital. The median disclosed round is $75M, with the middle half of rounds falling between $29M and $238M.

Institutional capital dominates this cluster. Recurring presence from firms like ARCH Venture Partners and Flagship Pioneering indicates a preference for platform technologies over single assets. These backers favor early stages, which means the segment contains many stealthy ventures. Sales cycles here align with long R&D timelines and deep pockets.

Biotechnology funded startup statistics in South San Francisco

Funded Biotechnology startups in South San Francisco
60
tracked in the database
Funding rounds, last 12 months
21
38 over 24 months
Disclosed capital raised, 24 months
$5.2B
38 of 38 rounds disclosed an amount
Median round size
$75M
middle half $29M to $238M

Most recent funding round on record: Aug 2026.

60 most recently funded Biotechnology startups in South San Francisco

60 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

E
South San Francisco, United States · Biotechnology
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Series C ·
$90M
N
South San Francisco, United States · Biotechnology
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders. Its…
Series B ·
$74M
I
South San Francisco, United States · Biotechnology
IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of…
Series Unknown ·
$345M
N
South San Francisco, United States · Biotechnology
NewLimit is a biotechnology company dedicated to significantly increasing human healthspan. We are working on…
Series C ·
$435M
Q
South San Francisco, United States · Biotechnology
Quince Therapeutics is a clinical stage pharmaceutical company developing therapeutics based on data…
Series Unknown ·
$115M
A
South San Francisco, United States · Biotechnology
Atara Biotherapeutics, Inc. (@Atarabio) is an off-the-shelf, allogeneic T-cell immunotherapy company…
Series Unknown ·
$550k
A
South San Francisco, United States · Biotechnology
Allogene Therapeutics is a clinical stage immuno-oncology company. It is mainly engaged in the development…
Series Unknown ·
$200M
C
South San Francisco, United States · Biotechnology
Defeat the mutants.
Series Unknown ·
$37M
T
South San Francisco, United States · Biotechnology
Tacit Therapeutics created RNA-targeting treatments for devastating diseases. By repurposing pre-existing…
Series A ·
$19M
B
South San Francisco, United States · Biotechnology
BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery…
Series B ·
$60M
C
South San Francisco, United States · Biotechnology
Cellares develops the Cell Shuttle, to overcome the challenges associated with manufacturing so these…
Series D ·
$257M
A
South San Francisco, United States · Biotechnology
Addition Therapeutics focuses on developing RNA-only therapeutics using its proprietary PRINT technology.…
Series A ·
$100M
S
South San Francisco, United States · Biotechnology
Structure Therapeutics develops groundbreaking medications for patients using cutting-edge computational and…
Series Unknown ·
$748M
V
South San Francisco, United States · Biotechnology
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative…
Series Unknown ·
$261M
F
South San Francisco, United States · Biotechnology
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products…
Series Unknown ·
$75M
T
South San Francisco, United States · Biotechnology
The EVERY Company is the market leader in engineering, manufacturing and formulating animal-free, animal…
Series D ·
$55M
S
South San Francisco, United States · Biotechnology
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune…
Series Unknown ·
$300k
R
South San Francisco, United States · Biotechnology
A clinical-stage biopharmaceutical business rooted on immunology, RAPT Therapeutics is dedicated to finding,…
Series Unknown ·
$250M
K
South San Francisco, United States · Biotechnology
Kardigan is a heart health company that is changing the way cardiovascular medications are developed by…
Series B ·
$254M
M
South San Francisco, United States · Biotechnology
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal…
Series Unknown ·
$24M
G
South San Francisco, United States · Biotechnology
Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical…
Series Unknown ·
$20M
S
South San Francisco, United States · Biotechnology
Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways…
Series Unknown ·
$1.0M
T
South San Francisco, United States · Biotechnology
Titan Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative treatments for…
Series Unknown ·
$1.0M
S
South San Francisco, United States · Biotechnology
Surrozen is a biotechnology company that is researching and creating drug candidates that can target the Wnt…
Series Unknown ·
$175M
C
South San Francisco, United States · Biotechnology
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that…
Series Unknown ·
$5.0M
T
South San Francisco, United States · Biotechnology
Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of…
Series A ·
$101M
A
South San Francisco, United States · Biotechnology
ArsenalBio, established in 2019, is dedicated to developing immune cell therapies that are both highly…
Series C ·
$325M
N
South San Francisco, United States · Biotechnology
Noetik is a biotech company specializing in AI technology, utilizing advanced machine learning to find and…
Series A ·
$40M
S
South San Francisco, United States · Biotechnology
Shinobi Therapeutics specializes in developing hypoimmune CD8αβ iPS-T cells that collaborate with the immune…
Series A ·
$68M
M
South San Francisco, United States · Biotechnology
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin…
Series Unknown ·
$14M
N
South San Francisco, United States · Biotechnology
NGM Biopharmaceuticals is a privately-owned company dedicated to finding groundbreaking medicines that…
Series A ·
$122M
C
South San Francisco, United States · Biotechnology
Cytokinetics is a late-stage biopharmaceutical organization zeroed in on finding, creating and…
Series Unknown ·
$550M
S
South San Francisco, United States · Biotechnology
Sutro Biopharma is a company in the clinical stage of drug discovery, development, and manufacturing. They…
Series Unknown ·
$75M
D
South San Francisco, United States · Biotechnology
Deep Origin is a biotechnology company that provides a platform for research and development in the life…
·
$26M
G
South San Francisco, United States · Biotechnology
The purpose of GenEdit's establishment is to revolutionize gene therapies by developing advanced non-viral,…
Series A ·
$24M
O
South San Francisco, United States · Biotechnology
Our Story ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’…
Series Unknown ·
$85M
G
GigaMune
South San Francisco, United States · Biotechnology
In 2017, GigaMune emerged as a separate company from GigaGen. By utilizing mass T cell receptor (TCR)…
Seed ·
Undisclosed
P
South San Francisco, United States · Biotechnology
Malleable Therapeutics is a clinical stage biopharmaceutical organization zeroed in on finding and creating…
Series Unknown ·
$250M
P
South San Francisco, United States · Biotechnology
Prothena Corporation plc is a late-stage clinical company with expertise in protein dysregulation and a…
Series Unknown ·
$172M
N
South San Francisco, United States · Biotechnology
Novome Biotechnologies, Inc. is a biotechnology company focused on engineering defined activities into the…
Series B ·
$44M
S
South San Francisco, United States · Biotechnology
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The…
Series B ·
$33M
A
South San Francisco, United States · Biotechnology
Annexon is a clinical-stage biopharmaceutical organization fostering a pipeline of novel treatments for…
Post-IPO Equity ·
$130M
D
South San Francisco, United States · Biotechnology
The very first moment Biopharmaceuticals is a biotechnology organization that spotlights on growing new…
Post-IPO Equity ·
$173M
M
South San Francisco, United States · Biotechnology
MiNDERA Dx conducts innovative work on harmless atomic testing for skin malignant growth and other skin…
Debt Financing ·
$2.1M
C
South San Francisco, United States · Biotechnology
They aspire to control the immune system. By the time a patient is sitting in front of an oncologist, cancer…
Grant ·
$7.5M
S
South San Francisco, United States · Biotechnology
Secure Transfusion Services is a life sciences company that aims to improve the quality and availability of…
Debt Financing ·
$15M
T
South San Francisco, United States · Biotechnology
TRexBio is a discovery stage biotechnology company leveraging cutting-edge computational biology tools, a…
Series A ·
$26M
F
South San Francisco, United States · Biotechnology
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits…
Post-IPO Equity ·
$250M
A
South San Francisco, United States · Biotechnology
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative…
Series A ·
$47M
C
South San Francisco, United States · Biotechnology
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity. With…
Venture - Series Unknown ·
$28M
I
South San Francisco, United States · Biotechnology
InterVenn focuses on the identification, quantification, and classification of Glycoproteomic and other PTM…
Series C ·
$201M
I
South San Francisco, United States · Biotechnology
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional…
·
$60M
G
South San Francisco, United States · Biotechnology
At Graphite Bio, they are rapidly building a next-generation gene editing company that is driven to apply…
Series B ·
$150M
I
South San Francisco, United States · Biotechnology
Insitro is an operator of a data-driven drug discovery and development company that utilizes machine learning…
Series C ·
$400M
E
South San Francisco, United States · Biotechnology
Earli’s mission is to make cancer a benign experience. Cancers are detected early when they are homogeneous;…
Series A ·
$40M
I
South San Francisco, United States · Biotechnology
InterVenn focuses on the identification, quantification, and classification of Glycoproteomic and other PTM…
·
$34M
F
South San Francisco, United States · Biotechnology
Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a…
·
$50M
E
South San Francisco, United States · Biotechnology
Escape Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat…
·
$73M
G
South San Francisco, United States · Biotechnology
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic…
·
$300k
E
South San Francisco, United States · Biotechnology
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
·
$135M

Funding stages of funded Biotechnology startups in South San Francisco

How the last 24 months of funding rounds for funded Biotechnology startups in South San Francisco break down by stage.

Stage
Rounds, last 24 months

A further 24 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology startup funding data in South San Francisco

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 60 funded Biotechnology startups in South San Francisco currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (0 of 38 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology startups in South San Francisco is dated Aug 2026.

The table above shows the 60 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology startups are there in South San Francisco?

FundedIQ tracks 60 funded Biotechnology startups in South San Francisco. This page lists the 60 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology startups in South San Francisco raised?

Biotechnology startups in South San Francisco tracked by FundedIQ have raised $5.2B in disclosed capital across 38 funding rounds over the last 24 months, including 21 rounds in the last 12 months. 38 of those 38 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

What is a typical funding round size for Biotechnology startups in South San Francisco?

The median disclosed round over the last 24 months is $75M, and the middle half of rounds fall between $29M and $238M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology startups in South San Francisco?

Series A is the most common labelled stage, with 5 rounds in the last 24 months, ahead of Series B (4) and Series C (3). A further 24 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology startup funding data in South San Francisco updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology startups in South San Francisco is dated Aug 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.